Calcinosis (sub-epidermal deposition of calcium salts; mainly hydroxyapatite, HAp)1 is a major clinical problem in patients with connective tissue disorders, in particular systemic sclerosis (SSc) where it affects ~ 20–40% of patients. This evidence concerns the gene HAP1 and systemic sclerosis.